• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Open Letter from Mallinckrodt Investor Reporting Fraud Reported to U.S. Securities and Exchange Comm

Quote

anonymous

Guest
"Accounting Fraud, Bankruptcy Fraud, Insider Trading, Proxy Fraud, and Electoral Fraud - Mallinckrodt Plc."

October 22, 2021, open letter to the U.S. Securities and Exchange Commission: https://www.sec.gov/Archives/edgar/data/1567892/000106299321009816/exhibit99-2.htm

October 22, 2021, open letter to the Mallinckrodt Plc. board of directors: https://www.sec.gov/Archives/edgar/data/1567892/000106299321009816/exhibit99-3.htm

October 14, 2021, open letter to Mallinckrodt Plc. lawyers on imprisonable violations of Irish law: https://www.sec.gov/Archives/edgar/data/1567892/000106299321009546/exhibit99-2.htm
 
























Top Bottom
Back
Quote